In the future, it will be necessary to further investigate the mechanisms of osteocalcin in neurodegenerative diseases and provide more experimental evidence for the use of osteocalcin as a potential peripheral target for the treatment of neurodegenerative diseases. This evidence concerns the gene BGLAP and neurodegenerative disease.